When was PulseMedica founded?

PulseMedica was founded in 2018.

Where is PulseMedica located?

PulseMedica is headquartered in Edmonton, Canada. It is registered at 441 Rennie Road, Miramichi.

Who is the current CEO of PulseMedica?

Nir Katchinskiy of PulseMedica. They have also founded 1 company.

How many employees does PulseMedica have?

As of Jun 30, 2026, the latest employee count at PulseMedica is 43.

Is PulseMedica a funded company?

PulseMedica is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does PulseMedica rank among its competitors?

PulseMedica ranks 24th amongst 45 active competitors, of which 13 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Maculaser, which secured an undisclosed amount in May, 2026.

Who are the top competitors of PulseMedica?

PulseMedica's top competitors include Neurotech, Eyedaptic and Cerevast. Among them, Maculaser secured the most recent funding round in May, 2026.

PulseMedica - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of proprietary 3D imaging and laser device for retinal surgery. It offers its patented device for femtosecond laser ophthalmic treatment for retinal diseases like age-related macular degeneration (AMD) and glaucoma.

Website: www.pulsemedica.com/
Email ID: *****@pulsemedica.com
Registered Address: 441 Rennie Road, Miramichi

Key Metrics

Founded Year

2018

Location

Edmonton, Canada

Stage

Funding Raised

Investors

Startup TNT

Ranked

24^th among 45 active competitors

Employee Count

43 as on Jun 30, 2026

Similar Companies

Neurotech & 51 more

View PulseMedica's full profile

PulseMedica is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Pulsemedica Corp. CIN: 10571822 , Canada, Active	Jan 08, 2018	-	-	-

PulseMedica is a funded company. PulseMedica has 1 institutional investor.

View details of PulseMedica's funding rounds and investors

The founders of PulseMedica are Nir Katchinskiy and Abdul Elezzabi. Nir Katchinskiy is the CEO of PulseMedica.

Here are the details of PulseMedica's key team members:

Nir Katchinskiy: Co-Founder & CEO of PulseMedica. They serve on the board of 1 company.
Contact Info: 1 email address
Abdul Elezzabi: Co-Founder of PulseMedica.

PulseMedica's Board of Directors

PulseMedica's board has 5 active members. Ray Muzyka, Nir Katchinskiy, Lahav Gil, James V. Mazzo and Bruce Jenett are independent board members.

Here is the list of PulseMedica's board of directors:

Name	Type	Representing	Status	Duration
Ray Muzyka	Independent board member	-	Current	4y 5m
{tzpcgq	Independent board member	-	Current	8y 7m
asqinwt	Independent board member	-	Current	4y 4m
ktfsahr	Independent board member	-	Current	1y 2m
hpypjkp	Independent board member	-	Current	1y 4m

View details of PulseMedica's Founder profiles and Board Members

PulseMedica's employee count trend

PulseMedica has 43 employees as of Jun 26. Here is PulseMedica's employee count trend over the years:

Uncover PulseMedica's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PulseMedica include Neurotech, Eyedaptic and Cerevast. Here is the list of Top 10 competitors of PulseMedica, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neurotech 2000, Cumberland (United States), Series B	Developer of a cell-based delivery device for the treatment of eye diseases	$53.3M	Atlas Venture, Apax & 12 others	57/100
2nd	Eyedaptic 2016, Laguna Niguel (United States), Seed	Smart glasses enhancing vision for macular degeneration and low vision	$1.47M	Crescite Ventures, New York Angels & 2 others	52/100
3rd	Cerevast 2009, Bothell (United States), Series C	Medical device company developing innovative ultrasound and microsphere therapies	$46.9M	Swiftsure, Haiyin Capital	50/100
4th	Second Sight 2000, Los Angeles (United States), Public	Provider of an implantable visual prosthetic for blind individuals	$36.9M	Versant Ventures, MDB Capital & 2 others	49/100
5th	Maculaser 2018, Espoo (Finland), Seed	Developer of laser therapy for the treatment of retinal diseases	$1.45M	Innovestor, ZEISS & 3 others	48/100
6th	RecensMedical 2016, Ulsan (South Korea), Public	Developer of an anesthetic medical device for retinal diseases	-	Intops Investment, SOORIM venture capital ... & 3 others	47/100
7th	Pixium Vision 2011, Paris (France), Public	Provider of bionic vision restoration systems	$32.5M	Sofinnova Partners, Lifeblood Capital & 11 others	46/100
8th	iScience Interventional 1999, Menlo Park (United States), Acquired	Innovative medical device company focused on interventional solutions	$36.7M	Medtronic, Affinity Capital Management & 11 others	44/100
9th	Pykus Therapeutics 2016, Boston (United States), Seed	Develops a dissolvable intraocular device for use during retinal surgery	$2.49M	Mass General Brigham Ventures, Hongsen Investment ... & 5 others	37/100
10th	Medical Instrument Development Laboratories 1981, San Leandro (United States), Acquired	Innovating ophthalmic surgical devices to prevent blindness and improve global vision	$50M	Orbimed, SBCVC & 3 others	37/100
24th	PulseMedica 2018, Edmonton (Canada), Funding Raised	Developer of proprietary 3D imaging and laser device for retinal surgery	-	Startup TNT	28/100